Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigator Driven Randomized Controlled Trial of Cefiderocol Versus Standard Therapy for Healthcare Associated and Hospital Acquired Gram-negative Blood Stream Infection: Study Protocol (the GAME CHANGER Trial)

NCT03869437 is registered in ClinicalTrials.gov with The University of Queensland as lead sponsor.

NCT NCT03869437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03869437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigator Driven Randomized Controlled Trial of Cefiderocol Versus Standard Therapy for Healthcare Associated and Hospital Acquired Gram-negative Blood Stream Infection: Study Protocol (the GAME CHANGER Trial)
Lead sponsor
The University of Queensland
Phase
Phase 2
Overall status
Completed
Start date
October 28, 2019
Completion date
January 29, 2024
Enrollment
513 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

bloodstream infections